Analyst Reco. Myomo, Inc.

Equities

MYO

US62857J2015

Market Closed - Nyse Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
3.54 ^USD	+2.91%		+25.53%	-29.34%

Mar. 28	Myomo, Inc. Appoints Heather Getz as Class II Director and Chair of Audit Committee	CI
Mar. 07	Transcript : Myomo, Inc., Q4 2023 Earnings Call, Mar 07, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Myomo, Inc. Announces CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro for Review at the Upcoming HCPCS Public Meeting	Nov. 06	CI
Maxim Initiates Myomo at Buy With $2 Price Target	23-05-25	MT
Alliance Global Lowers Myomo's Price Target to $6.70 From $10, Maintains Buy Rating	22-07-08	MT
Alliance Global Partners Adjusts Myomo Price Target to $19 From $34, Maintains Buy Rating	22-03-10	MT
Alliance Global Partners Adjusts Myomo PT to $34 From $36.50, Maintains Buy Rating	21-11-11	MT
MYOMO : Alliance Global Starts Myomo at Buy with $36.50 Price Target	21-06-10	MT
MYOMO : Roth Capital Upgrades Myomo to Buy From Neutral, Adjusts Price Target to $7 From $5	20-11-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer